MENU

XCUR Stock Exicure (XCUR, $0.4) Stochastic Oscillator left the oversold zone on June 07, 2024

A.I.dvisor
at Tickeron.com
06/08/24
Loading...
XCUR - Exicure
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $0.3961
Daily change: -$0.0774 (-16.35%)
Daily volume: 199.1K
Capitalization: $3.4M
Industry: Biotechnology
This is a signal that XCUR's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 71 similar cases where XCUR's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

XCUR sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for XCUR moved above the 200-day moving average on October 31, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where XCUR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 31, 2024. You may want to consider a long position or call options on XCUR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XCUR just turned positive on October 31, 2024. Looking at past instances where XCUR's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

XCUR moved above its 50-day moving average on November 08, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XCUR advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XCUR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XCUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.283) is normal, around the industry mean (14.655). P/E Ratio (0.187) is within average values for comparable stocks, (96.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.824). XCUR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (11.013) is also within normal values, averaging (218.428).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XCUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
XCUR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of clinical stage biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2430 N. Halsted Street
Phone
+1 847 673-1700
Employees
13
Web
https://www.exicuretx.com